OptionsHouse

Options Trading News

January 18, 2013  Fri 7:35 AM CT

MS: SEE CHART GET CHAIN FIND STRATEGIES

Profit Comes in Better Than Expected

Morgan Stanley reported fourth-quarter earnings of $0.28 a share, beating the $0.27 average analyst forecast. Revenue missed expectations, but investors are focusing on that profit number, sending MS up by more than 6 percent before the bell on my tradeMONSTER platform.

FDA Approves Migraine Skin Patch

NuPath announced late yesterday that the Food & Drug Administration approved its Zecuity skin patch for the treatment of migraines, making it the first such product on the market. PATH rallies 19 percent on the news.

Research in Motion Keeps Moving

Research in Motion keeps moving! Today, it was upgraded to "buy" from "hold" at Jefferies, which cited the possibility of its Blackberry mail being able to work on iPhones and Android devices. The target price was raised to $19.50 from $13. RIMM is up 7 percent in the premarket.

Capital One Drops on Earnings Miss

Capital One earned just $1.41 a share in the fourth quarter on revenue of $5.62 billion. Analysts had expected $1.58 and $5.71 billion, respectively. Those results have COF down 7 percent in early trading.

Share this article with your friends


Related Stories

MS

Downside trade in Morgan Stanley

February 20, 2015

The financial name has fallen under pressure with the rest of the sector since the Federal Reserve indicated that it was in no rush to raise interest rates.

OptionsHouse

TRADING WEEKLY OPTIONS

The fastest money in the market
View full report »

Premium Services

Webinar Recording

Turbo Charge Your Trading Profits

Education & Strategy

Gamma

As we continue to discuss the Greeks, we come to the first of the strike based Greeks called Gamma. Gamma is known as the second derivative, while delta is the first.

View more education articles »